Advertisement

Topics

Another Study Ties Pioglitazone to Bladder Cancer Risk (CME/CE)

09:00 EDT 10 Aug 2017 | MedPageToday

(MedPage Today) -- Risk emerged within first 2 years; attenuated after discontinuing

Original Article: Another Study Ties Pioglitazone to Bladder Cancer Risk (CME/CE)

NEXT ARTICLE

More From BioPortfolio on "Another Study Ties Pioglitazone to Bladder Cancer Risk (CME/CE)"

Quick Search
Advertisement